Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/1a/69/9b/1a699bfe-2bb8-43e7-c19a-1abddc1bbbf7/mza_9273680668163317928.jpg/600x600bb.jpg
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
UCARE, the Global Allergy and Asthma Excellence Network for Urticaria
113 episodes
1 day ago
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/
Show more...
Science
RSS
All content for All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier is the property of UCARE, the Global Allergy and Asthma Excellence Network for Urticaria and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/42928867/42928867-1749038815327-b39be0954086b.jpg
Females, Pregnancy & Chronic Urticaria: What Doctors Should Know
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
18 minutes 51 seconds
5 months ago
Females, Pregnancy & Chronic Urticaria: What Doctors Should Know

In this episode, Dr. Sophia Neisinger welcomes Prof. Emek Kocatürk, leading urticaria researcher and UCARE expert from Istanbul, to explore the gender-specific aspects of chronic urticaria, with a special focus on pregnancy. 


They discuss: 

🔹 Why do more women than men suffer from chronic urticaria? 
🔹 How does pregnancy affect urticaria symptoms and treatment response? 
🔹 What medications are safe during pregnancy and breastfeeding? 
🔹 How should physicians approach treatment decisions with female patients? 

Prof. Kocatürk shares key insights from the PREG-CU study, involving over 300 pregnant CSU patients, and explains why half of them improve during pregnancy. She outlines practical treatment guidelines for antihistamines and omalizumab use during pregnancy and breastfeeding, discusses estrogen’s inflammatory role, and gives tips for shared decision-making in clinical care. 

Join us for an important and empowering episode that sheds light on female-specific urticaria challenges and how to manage them with evidence-based confidence.


Key Learnings from the Episode 

70% of CSU patients are female, pointing to hormonal and autoimmune factors in disease susceptibility. 

Female CSU patients suffer more: more angioedema, systemic symptoms, worse disease control, and more comorbidities like asthma, thyroid disease, and depression. 

The PREG-CU study showed that 50% of CSU patients improve during pregnancy, offering hope to women planning to conceive. 

Exacerbations during pregnancy are common and linked to worse pregnancy outcomes if untreated. 

Antihistamines (especially cetirizine, loratadine) are safe in pregnancy; second-generation agents are preferred. 

Omalizumab is safe in pregnancy and lactation, particularly starting in the second trimester. 

Antihistamines can be safely continued and even up-dosed during breastfeeding. 

Keeping CSU under control during and after pregnancy is essential for maternal well-being and newborn bonding. 

Shared decision-making and good counseling reduce fear and improve patient experience. 

Digital tools, registries like CURE and CARE, and collaborative research are key to improving care for women with urticaria. 


Chapters 

00:00 Understanding Chronic Urticaria: A Female Predominance 

06:20 Pregnancy and Chronic Urticaria: What to Expect 

11:36 Managing Urticaria During Pregnancy and Lactation 

17:18 Fun Facts and Closing Thoughts

 

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.


Feedback form:

ATU: ⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH


All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
Since 2020 this podcast is an invaluable resource for health care professionals, and anyone interested in learning more about urticaria. In the first 97 episodes, Prof. Marcus Maurer († 31.07.2024) is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Prof. Torsten Zuberbier has taken on this role. All opinions expressed are those of the faculty. This content should not be taken as medical advice and is for informational purposes only. Learn more about the network and its activities here: https://ucare-network.com/